Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TELA Bio (TELA) Research & Development (2018 - 2025)

TELA Bio has reported Research & Development over the past 8 years, most recently at $2.1 million for Q4 2025.

  • Quarterly results put Research & Development at $2.1 million for Q4 2025, up 4.93% from a year ago — trailing twelve months through Dec 2025 was $9.2 million (up 4.62% YoY), and the annual figure for FY2025 was $9.2 million, up 4.62%.
  • Research & Development for Q4 2025 was $2.1 million at TELA Bio, down from $2.3 million in the prior quarter.
  • Over the last five years, Research & Development for TELA hit a ceiling of $2.7 million in Q4 2022 and a floor of $1.4 million in Q3 2021.
  • Median Research & Development over the past 5 years was $2.1 million (2022), compared with a mean of $2.2 million.
  • Biggest five-year swings in Research & Development: soared 97.14% in 2021 and later dropped 24.43% in 2024.
  • TELA Bio's Research & Development stood at $1.7 million in 2021, then surged by 58.03% to $2.7 million in 2022, then fell by 1.5% to $2.7 million in 2023, then fell by 24.43% to $2.0 million in 2024, then grew by 4.93% to $2.1 million in 2025.
  • The last three reported values for Research & Development were $2.1 million (Q4 2025), $2.3 million (Q3 2025), and $2.2 million (Q2 2025) per Business Quant data.